Navigation Links
Varian, Inc. Reports Third Quarter 2008 Results
Date:7/23/2008

Third Quarter FY 2008 and Third Quarter FY 2007

and

First Nine Months FY 2008 and First Nine Months FY 2007

Fiscal Quarter Ended Nine Months Ended

-------------------- -------------------

June 27, June 29, June 27, June 29,

2008 2007 2008 2007

--------- --------- --------- ---------

TOTAL COMPANY (Continued)

-------------------------

Income Tax Expense

U.S. GAAP as reported $6,823 $7,291 $24,463 $24,326

Adjustments:

Tax impact of adjustments:

Share-based

compensation expense 659 777 1,922 2,863

Acquisition-related

intangible amortization 747 635 2,025 2,088

Acquisition-related inventory

write-up amortization 161 - 410 158

Impairment of private

company equity investment - - 1,154 -

Restructuring and

other related costs 597 1,018 1,538 1,071

--------- --------- --------- ---------

As adjusted $8,987 $9,721 $31,512 $30,506

========= ========= ========= =========

Net Earnings

U.S. GAAP as reported $11,366 $14,551 $44,737 $46,188

Adjustments:

Share-based

compensation expense 1,645 1,352 5,042 4,980

Acquisition-related

in-process research

and development charge 1,488 - 1,488 -

Acquisition-
'/>"/>

SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. James T. Glover Appointed to Board of Directors of Varian, Inc.
2. New Capillary Column From Varian, Inc. Offers Durability and Performance for High Temperature GC and GC/MS
3. New FT-IR Spectrometer Series from Varian, Inc.
4. New Dual Cold Probe From Varian, Inc. Increases Sensitivity and Reduces Analysis Times for 13C NMR Experiments
5. Double Resonance Probe for Liquid State NMR Applications From Varian, Inc. Increases Productivity for Routine Analyses
6. New FTMS System From Varian, Inc. Offers Switchable LC and GC Sources and True Triple Quadrupole Capabilities
7. New Chromatography Detectors From Varian, Inc. Extend the Range of Universal Detection for HPLC and LC/MS
8. Varian, Inc. Reports First Quarter 2008 Results
9. Nuvelo Reports Second Quarter 2008 Financial Results
10. Genzyme Reports Strong Second-Quarter Growth
11. Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2008).... 28 /- Truman Medical Centers (TMC),...ates to install the,Siemens SOMATOM Definition AS ...canner is a highly adaptive scanner, providing exc...sure to the patient., "To be one of the first med..., first of its kind, state-of-the-art technology c...
(Date:8/28/2008)...28 /- Barr Pharmaceuticals,...diary, Barr Laboratories,Inc., received final app...A) to manufacture and market a generic version of ...drobromide), 4 mg, 8 mg and 12 mg tablets. Barr,in...ct immediately., Barr filed an Abbreviated New Dr...
(Date:8/28/2008)...st 28 /- ThromboGenics NV,(...ocused on innovative,treatments for eye disease, v...iness update and its financial results for the six...irst half of 2008, ThromboGenics has achieved a nu...ompany to successfully pursue the,next stage of it...
(Date:8/28/2008)... CoreValve ( www.corevalve.com ) announced today t...uation of its proprietary percutaneous ReValving S...mounted in a self-expanding frame, was initiated l...f. (Business Wire EON) August 28, 2008 -- The fir...ystem were performed in two days by John Ormiston,...
Breaking Biology Technology:Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the World's First Adaptive 128-slice CT Scanner 2Barr Receives Approval for Generic Version of Razadyne(R) Tablets 2Barr Receives Approval for Generic Version of Razadyne(R) Tablets 3Barr Receives Approval for Generic Version of Razadyne(R) Tablets 4Barr Receives Approval for Generic Version of Razadyne(R) Tablets 5ThromboGenics Announces Half Year Results 2008 2ThromboGenics Announces Half Year Results 2008 3ThromboGenics Announces Half Year Results 2008 4ThromboGenics Announces Half Year Results 2008 5 CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries 2
...eteran television reporter recently asked me to na... can expect to find jobs after they complete their...f I did know, I would invest every penny I have in... , ,But as another Labor Day passes in Wisconsin, ...more than a glib answer. Nervousness about the eco...
... The U.S. Department of Health and Human Services ...nal Centers of Excellence (RCE) for Biodefense and...sity of Wisconsin-Madison is collaborating with 11...ern center as part of a $350 million national init...sity of Chicago and Northwestern University will r...
...bread and butter of Wisconsins economic growth wil...investment capital to transfer our best technology...ion, maintaining a strong education system, and en...ce to support all businesses. , ,But theres a huma...al to Wisconsins future as venture capital, less r...
...- Catalyst International, Inc. a provider of sup... two new products that improve supplier compliance...eling capabilities via the Internet. CatalystConne...of an open-architecture based solutions suite, Sup...ML interface standards. The system can be easily i...
Other Biology Technology:Heres how todays Wisconsin children will find jobs tomorrow 2Heres how todays Wisconsin children will find jobs tomorrow 3UW-Madison Gets Federal Biodefense Funds 2Athletics, pop culture and the arts 2Athletics, pop culture and the arts 3Software Enables Suppler Customer Data Integration 2
(Date:8/28/2008)..., Troy, N.Y. The advantage of using two eyes t... solely with our capacity to see in 3-D. Now, a ne... Institute has uncovered a truly eye-opening advan...gh things. , Most animals fish, insects, reptil... in non-cluttered environments like fields or plai...
(Date:8/28/2008)... Researchers at The University of Nottingham have ...develop a new drug that could ease the suffering o...who are unable to take beta-blockers. , In the U...d most are able to have their symptoms effectively...gs which stop adrenaline from making the heart wor...
(Date:8/27/2008)...,, DALLAS Aug. 28, 2008 Researchers at UT So...that the brain must create new nerve cells for eit...on-like behavior. , In addition, the researchers...ame biochemical pathway to exert their effects. ,...chanisms of antidepressants and provide a new dire...
(Date:8/27/2008)... INDIANAPOLIS Indiana University researchers have...e complex problems of scientific collaboration. ,...aborative social networking for the science commun... manage research papers and data, organize groups ...nd customize personal and group profiles all onli...
Breaking Biology News(10 mins):Study says eyes evolved for X-Ray vision 2Study says eyes evolved for X-Ray vision 3New beta-blocker to offer hope to heart and lung sufferers 2Antidepressants need new nerve cells to be effective, UT Southwestern researchers find 2Indiana U researchers launch social networking and research management tool for scientists 2Nile Therapeutics to Present at the Rodman 26 Renshaw 9th Annual Healthcare Conference 1508 1Nile Therapeutics to Present at the Rodman 26 Renshaw 9th Annual Healthcare Conference 1508 2Study Shows VAPRISOL 28R 29 is Effective in Increasing Serum Sodium Levels and Well Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia 660 1Study Shows VAPRISOL 28R 29 is Effective in Increasing Serum Sodium Levels and Well Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia 660 2Study Shows VAPRISOL 28R 29 is Effective in Increasing Serum Sodium Levels and Well Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia 660 3Study Shows VAPRISOL 28R 29 is Effective in Increasing Serum Sodium Levels and Well Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia 660 4Study Shows VAPRISOL 28R 29 is Effective in Increasing Serum Sodium Levels and Well Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia 660 5Psychiatrists parents significantly differ in ADHD psychiatric comorbidities perceptions 4596 1Psychiatrists parents significantly differ in ADHD psychiatric comorbidities perceptions 4596 2Study finds multiple neglected tropical diseases effectively treated with drugs 4593 1Study finds multiple neglected tropical diseases effectively treated with drugs 4593 2
...er since the Norwegians expanded commercial farmin...ed to rapidly grow worldwide. It has expanded to s...ummeted and, there is concern that farmed fish may... escaping from marine net pens might become an inv...laska," says research fish biologist Peter Bisson....
... international team of scientists has discovered t...ul stomach ulcers has been present in the human di...ca over 60,000 years ago. The research, published ...ot only furthers our understanding of a disease ca...the migration and diversification of early humans....
...ientists have discovered that increased levels of ...ve resulted in unexpected changes in oceanic chemi...d in the March 7, 2007, issue of the journal Geoph... Mexico Tech and his colleagues conducted a month-...resent-day carbon dioxide concentrations and ocean...
...male Antarctic fur seals will travel across a colo...verse and unrelated, rather than mate with local d...week,s Nature, suggest that female choice may be m...and that such strategies enable species to maintai...ity of Cambridge and the British Antarctic Survey ...
Other Biology News:Farmed salmon could become an invasive species in forest streams 2Prehistoric origins of stomach ulcers uncovered 2Scientists uncover link between ocean's chemical processes and microscopic floating plants 2Female Antarctic seals give cold shoulder to local males 2
...of the LVF-UV-HL, LVF-CUV-ADP, FHS-LVF and CVD-Dif...w-pass Linear Variable Filters to create the world...velength and adjustable bandpass. Each filter feat...cking band (99.8%). These filters -- with interfe...
Agar, 500 g. Noble Agar.Moisture: < 10%, ash: < 1.6%, EEO (-mr): < 0.450 (pH 8.4). Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals .
Ms anti-Cyclophilin D
Intended to qualitatively detect EGFR gene amplification in formalin-fixed, paraffin-embedded (FFPE) tissue sections, metaphase chromosome spreads, and cell preparations, using Chromogenic In Situ Hy
Biology Products: